Skip to main content

Table 1 Patients with and without anti-neuronal antibodies were compared on the following clinical characteristics

From: The significance of anti-neuronal antibodies for acute psychiatric disorders: a retrospective case–controlled study

Clinical characteristic NMDAR CASPR2 GAD65 Variable Obtained Definitions
Hallucinations X X n/a Dichotome (Yes/No) Retrospective Vis., aud., tact. and/or olf.
Delusions X X n/a Dichotome (Yes/No) Retrospective Described in chart
Lowered mood X X X Dichotome (Yes/No) Retrospective Described in chart
Elevated mood X n/a n/a Dichotome (Yes/No) Retrospective Described in chart
Irritability X n/a X Dichotome (Yes/No) Prospective Brøset Violence Checklist
Disorientation X X X Dichotome (Yes/No) Prospective Brøset Violence Checklist
Disinhibition X n/a n/a Continuous (1–7) Prospective PANSS Item G14
Agitation X X X Continuous (5–35) Prospective PANSS-EC
Symptom fluctuation X n/a n/a Continuous (1–10) Prospective SOMAS Item A
Total sleep time (actigraphy) X X n/a Continuous (min) Prospective According to actigraphy software algorithms
Wake after sleep onset (actigraphy) X X n/a Continuous (min) Prospective According to actigraphy software algorithms
  1. aud auditive, CASPR2 contactin-associated protein 2, GAD65 glutamic acid decarboxylase 65, n/a not applicable (because the systematic literature search did not reveal associations between the symptom variable and the specific antibody), NMDAR N-methyl-d-aspartate receptor, olf olfactory, PANSS positive and negative syndrome scale, PANSS-EC positive and negative syndrome scale- excited component, SOMAS Symptomatic Organic Mental Disorder Assessment Scale, tact tactile, Vis visual